Aerpio Pharmaceuticals
Pharmaceutical ManufacturingOhio, United States11-50 Employees
Aerpio Pharmaceuticals is a pharmaceuticals company based out of 9987 Carver Road Suite 420, Cincinnati, Ohio, United States.
Merger Opportunities Aerpio Pharmaceuticals has been actively involved in mergers and partnerships recently, providing potential opportunities for sales collaborations or cross-selling of products and services to new entities formed through these mergers.
Fundraising Events The company has successfully raised $155 million through private investment in public equity financing, indicating a strong financial position. This could present sales opportunities to offer financial services or products to support future fundraising events or investments.
Licensing Agreements With licensing and collaboration agreements in place with other pharmaceutical companies like Gossamer Bio, there may be opportunities for sales of complementary products or technologies to partners involved in these agreements.
Expansion in Clinical Trials Aerpio Pharmaceuticals is actively expanding its clinical trials, such as the development of treatments for conditions like inflammatory bowel disease and primary open angle glaucoma. Sales professionals could explore partnerships to provide support services or products for these trials.
Personnel Movements Key personnel movements, such as the departure of the Chief Medical Officer, Dr. Pakola, may open sales opportunities to provide services or solutions to fill the expertise gap left by departing executives or to new organizations where they join.
Aerpio Pharmaceuticals uses 8 technology products and services including W3 Total Cache, Segment, MySQL, and more. Explore Aerpio Pharmaceuticals's tech stack below.
Aerpio Pharmaceuticals Email Formats | Percentage |
FLast@aerpio.com | 43% |
Last@aerpio.com | 9% |
First@aerpio.com | 5% |
FLast@aerpio.com | 43% |
Pharmaceutical ManufacturingOhio, United States11-50 Employees
Aerpio Pharmaceuticals is a pharmaceuticals company based out of 9987 Carver Road Suite 420, Cincinnati, Ohio, United States.
Aerpio Pharmaceuticals has raised a total of $155M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $155Mas a investment in public equity (PIPE) financing round.
Aerpio Pharmaceuticals's revenue is in the range of $10M
Aerpio Pharmaceuticals has raised a total of $155M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $155Mas a investment in public equity (PIPE) financing round.
Aerpio Pharmaceuticals's revenue is in the range of $10M